Best practices for communicating clinical trial changes and delays

In the case of COVID-19, clinical trials – like many other planned activities – have been impacted and many companies have been forced to make some tough choices. When making the difficult, yet necessary, decision to delay a trial, communicating clearly and strategically across all affected audiences is critically important.

Unlocking virtual medical congresses

Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.